Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs.
about
Multifunctional nanoparticles: cost versus benefit of adding targeting and imaging capabilitiesVascular targeting of nanocarriers: perplexing aspects of the seemingly straightforward paradigmNanocarriers for vascular delivery of antioxidantsIcam-1 targeted nanogels loaded with dexamethasone alleviate pulmonary inflammationTargeted delivery of therapeutics to endothelium.Live dynamic imaging of caveolae pumping targeted antibody rapidly and specifically across endothelium in the lungAnchoring fusion thrombomodulin to the endothelial lumen protects against injury-induced lung thrombosis and inflammation.Imaging molecular expression on vascular endothelial cells by in vivo immunofluorescence microscopyTargeted endothelial delivery of nanosized catalase immunoconjugates protects lung grafts donated after cardiac death.Targeting endothelium and its dynamic caveolae for tissue-specific transcytosis in vivo: a pathway to overcome cell barriers to drug and gene deliverySHP-2 phosphatase activity is required for PECAM-1-dependent cell motility.NHLBI workshop report: endothelial cell phenotypes in heart, lung, and blood diseases.PECAM-targeted delivery of SOD inhibits endothelial inflammatory responseModulation of endothelial targeting by size of antibody-antioxidant enzyme conjugates.Targeting antioxidant and antithrombotic biotherapeutics to endothelium.Anti-inflammatory effect of targeted delivery of SOD to endothelium: mechanism, synergism with NO donors and protective effects in vitro and in vivo.Catalase and superoxide dismutase conjugated with platelet-endothelial cell adhesion molecule antibody distinctly alleviate abnormal endothelial permeability caused by exogenous reactive oxygen species and vascular endothelial growth factorTargeted modulation of reactive oxygen species in the vascular endotheliumFactors modulating the delivery and effect of enzymatic cargo conjugated with antibodies targeted to the pulmonary endothelium.Vascular immunotargeting of glucose oxidase to the endothelial antigens induces distinct forms of oxidant acute lung injury: targeting to thrombomodulin, but not to PECAM-1, causes pulmonary thrombosis and neutrophil transmigrationEndothelial targeting of a recombinant construct fusing a PECAM-1 single-chain variable antibody fragment (scFv) with prourokinase facilitates prophylactic thrombolysis in the pulmonary vasculature.Endothelial targeting of antibody-decorated polymeric filomicelles.Endothelial targeting of polymeric nanoparticles stably labeled with the PET imaging radioisotope iodine-124.Endothelial targeting of semi-permeable polymer nanocarriers for enzyme therapiesAntioxidant protection by PECAM-targeted delivery of a novel NADPH-oxidase inhibitor to the endothelium in vitro and in vivo.Prophylactic thrombolysis by thrombin-activated latent prourokinase targeted to PECAM-1 in the pulmonary vasculaturePECAM-1 isoforms, eNOS and endoglin axis in regulation of angiogenesisTargeting prostate cancer cells with a multivalent PSMA inhibitor-guided streptavidin conjugate.RhoA activation and actin reorganization involved in endothelial CAM-mediated endocytosis of anti-PECAM carriers: critical role for tyrosine 686 in the cytoplasmic tail of PECAM-1.Collaborative Enhancement of Endothelial Targeting of Nanocarriers by Modulating Platelet-Endothelial Cell Adhesion Molecule-1/CD31 Epitope Engagement.Non-affinity factors modulating vascular targeting of nano- and microcarriersTargeted nanoparticle-based drug delivery and diagnosis.Advanced drug delivery systems for antithrombotic agents.Targeted delivery of nucleic-acid-based therapeutics to the pulmonary circulation.An experimental and theoretical evaluation of the influence of pretargeting antibody on the tumor accumulation of effectorA semiempirical model of tumor pretargeting.Targeted detoxification of selected reactive oxygen species in the vascular endothelium.Acute and chronic shear stress differently regulate endothelial internalization of nanocarriers targeted to platelet-endothelial cell adhesion molecule-1.Vascular targeting of antithrombotic agents.Endothelial nanomedicine for the treatment of pulmonary disease.
P2860
Q27011598-C9823216-28DE-45E8-A7A2-22CD13605D2BQ27026630-3F8942F7-68ED-4DF2-AE4F-6DDCAD74E8CDQ27027067-2A1390BD-C32F-4B42-AF5F-B6A9F1A20CE4Q28540684-F9020DE0-5F22-48F5-9831-63041D72C3ACQ30475849-C286D3DD-3A15-479D-A7C7-108DE6BC6332Q30480068-930FADA5-4DA0-40C1-8CD2-A23D5AE4AFE3Q30489456-AE102685-7035-44E2-B3B4-11D963F1246FQ33571085-6A2F5701-EC37-452A-A563-3AFE32749BA7Q33893438-E997839A-6115-4AE8-8AE7-DBAC24B32751Q34011941-AA83154E-1A81-4DC3-8E63-0EA359B193DEQ34211722-8508DA61-A12E-42DD-AA85-66AF32F54850Q34400936-2FF5C239-02A3-4427-B788-97EE86EF4D57Q34421779-814D56FA-D93B-4ECB-8B45-3008E3DA97A3Q34593961-0F3FF6A5-B2EA-4BDB-9ADC-860F8A8F7E73Q34935960-A78FF073-20BC-4061-B0BF-C2CF4EE5CC5DQ35023022-BC65B01F-4A81-4298-BC02-0690D0403B64Q35077934-1E5E7654-B7DB-4EA5-974C-E8625D1C473BQ35098774-748995B8-1308-4E36-B252-437C1808DF92Q35759213-972EB6B5-5096-4159-AFAB-663625F0DF19Q35788765-4916AEA9-34DB-42D3-AD78-E89395482E63Q35848131-520AF195-0152-4B4E-BE98-D66ACF804908Q35930068-5668CD6D-B20A-4D40-A9D1-7E72C4B4E5D2Q35973379-18476308-9353-4DFC-8A6B-B5D86BA5343CQ36254445-1CDF60E1-2706-4867-BB8B-6F4A556C50AAQ36392586-761A393B-F584-417A-B244-B25920B048CEQ36445835-AC8943EB-2780-4CD4-B3E8-30E7DB9994A6Q36473318-3418CACA-B5F9-4D47-AE4E-5182E53382CBQ36477594-8555C0D2-513A-47ED-B960-E87D5945312BQ36491844-28186A63-C70E-40BE-AAC0-8E3087179570Q36601477-1DA2BAE7-298B-4A0F-B921-F5375949EA2BQ36703526-9784C33A-BE77-47C6-8D60-0534968056C0Q36799773-73F0BCCA-6291-4BA1-9102-4290737679E8Q37132620-17E80FA5-ADA2-4F66-8537-94C53236DA10Q37149082-FAE28C51-A347-4285-85A8-3C35060D40FBQ37154201-87E6CE45-E22B-4499-98B7-80FF469AB5B5Q37288717-1CAF141C-F4EE-46D6-9FD6-4BE766C59A42Q37416432-17DA2E72-9DB0-47A6-BE9C-F24D1443623CQ37416891-94A6FB4C-0378-4495-BBD7-8D842342F02EQ37902114-D0AE569E-B006-4C1A-B1E2-415DEA070568Q38267984-BD2B703B-5386-48FB-AE64-C151DDD89930
P2860
Streptavidin facilitates internalization and pulmonary targeting of an anti-endothelial cell antibody (platelet-endothelial cell adhesion molecule 1): a strategy for vascular immunotargeting of drugs.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 1999
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Streptavidin facilitates inter ...... ular immunotargeting of drugs.
@en
Streptavidin facilitates inter ...... anti-endothelial cell antibody
@nl
type
label
Streptavidin facilitates inter ...... ular immunotargeting of drugs.
@en
Streptavidin facilitates inter ...... anti-endothelial cell antibody
@nl
prefLabel
Streptavidin facilitates inter ...... ular immunotargeting of drugs.
@en
Streptavidin facilitates inter ...... anti-endothelial cell antibody
@nl
P2093
P2860
P356
P1476
Streptavidin facilitates inter ...... ular immunotargeting of drugs.
@en
P2093
A B Fisher
D W Harshaw
I Balyasnikova
M Christofidou-Solomidou
S M Albelda
V R Muzykantov
P2860
P304
P356
10.1073/PNAS.96.5.2379
P407
P577
1999-03-01T00:00:00Z